XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interest
Total
Beginning balance at Dec. 31, 2022 $ 22 $ 1,553,668 $ (829,975) $ (3,722) $ 7,478 $ 727,471
Beginning balance (in shares) at Dec. 31, 2022 222,437,429          
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock   332       332
Issuance of common stock (in shares) 470,351          
Shares withheld related to net share settlement   (175)       (175)
Stock-based compensation   6,096       6,096
Stock-based sales incentive charges   8,172       8,172
Net loss     (38,697)   (135) (38,832)
Other comprehensive income (loss)       705 0 705
Ending balance at Mar. 31, 2023 $ 22 $ 1,568,093 $ (868,672) $ (3,017) 7,343 703,769
Ending balance (in shares) at Mar. 31, 2023 222,907,780          
Beginning balance at Dec. 31, 2023 $ 22         $ 733,647
Beginning balance (in shares) at Dec. 31, 2023 223,026,966         223,026,966
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares) 236,089          
Net loss         (173) $ (18,616)
Other comprehensive income (loss)         $ 0 (875)
Ending balance at Mar. 31, 2024 $ 22         $ 729,609
Ending balance (in shares) at Mar. 31, 2024 223,263,055         223,263,055